PLEXUS ($PLXS) posted quarterly earnings results for Q1 2026 on Wednesday, January 28th. The company reported earnings of $1.78 per share, missing estimates of $1.79 by $0.01. The company also reported revenue of $1,069,849,999, missing estimates of $1,093,614,858 by $-23,764,859.
You can see Quiver Quantitative's $PLXS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PLEXUS Insider Trading Activity
PLEXUS insiders have traded $PLXS stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $PLXS stock by insiders over the last 6 months:
- TODD P. KELSEY (President & CEO) has made 0 purchases and 6 sales selling 10,000 shares for an estimated $1,391,685.
- PATRICK JOHN JERMAIN (Exec. VP & CFO) has made 0 purchases and 4 sales selling 8,676 shares for an estimated $1,200,714.
- OLIVER K. MIHM (Exec VP & COO) has made 0 purchases and 3 sales selling 6,177 shares for an estimated $862,749.
- ANGELO MICHAEL JR NINIVAGGI (Exec VP, CAO, Gen Coun & Secy) has made 0 purchases and 3 sales selling 5,423 shares for an estimated $775,548.
- VICTOR (PANG HAU) TAN (Regional President - APAC) has made 0 purchases and 2 sales selling 3,000 shares for an estimated $417,000.
- KAREN MARIE RAPP sold 500 shares for an estimated $71,735
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PLEXUS Hedge Fund Activity
We have seen 136 institutional investors add shares of PLEXUS stock to their portfolio, and 162 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIDUCIARY MANAGEMENT INC /WI/ added 417,022 shares (+44.6%) to their portfolio in Q3 2025, for an estimated $60,338,913
- AMERICAN CENTURY COMPANIES INC added 338,119 shares (+44.2%) to their portfolio in Q3 2025, for an estimated $48,922,438
- THRIVENT FINANCIAL FOR LUTHERANS added 298,117 shares (+inf%) to their portfolio in Q3 2025, for an estimated $43,134,548
- NUVEEN, LLC added 147,089 shares (+73.0%) to their portfolio in Q3 2025, for an estimated $21,282,307
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 144,068 shares (+127.5%) to their portfolio in Q3 2025, for an estimated $20,845,198
- MILLENNIUM MANAGEMENT LLC removed 130,052 shares (-60.2%) from their portfolio in Q3 2025, for an estimated $18,817,223
- CUBIST SYSTEMATIC STRATEGIES, LLC removed 106,330 shares (-96.7%) from their portfolio in Q3 2025, for an estimated $15,384,887
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PLEXUS Government Contracts
We have seen $388,783 of award payments to $PLXS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- CHARLEVOIX SUPERFUND DEMOLITION AND EXCAVATION: $177,004
- DLA-SM ESOHMS AUDIT BASE TASKS 1-5: $133,634
- CERCLA SUPPORT-LAND USE CONTROL INSPECTION AND GROUNDWATER MONITORING FOR H-AREA LANDFILL CELLS (90) AT SAV...: $78,145
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
PLEXUS Analyst Ratings
Wall Street analysts have issued reports on $PLXS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 01/28/2026
- Needham issued a "Buy" rating on 10/23/2025
To track analyst ratings and price targets for PLEXUS, check out Quiver Quantitative's $PLXS forecast page.
PLEXUS Price Targets
Multiple analysts have issued price targets for $PLXS recently. We have seen 3 analysts offer price targets for $PLXS in the last 6 months, with a median target of $165.0.
Here are some recent targets:
- David Williams from Benchmark set a target price of $195.0 on 01/28/2026
- Anja Soderstrom from Sidoti & Co. set a target price of $150.0 on 10/24/2025
- James Ricchiuti from Needham set a target price of $165.0 on 10/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
